ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2259

The Effects of Systematic Lupus Erythematosus Related Cognitive Impairments on Activities of Daily Living and Life Role Participation: A Qualitative Framework Study

Michelle Barraclough1, Aaron Howe2, Ana Soberanis2, Mahta Kakvan3, Vijay Chattu2, Ali Bani-Fatemi2, Lisa Engel4, Michelle Vitti5, Emily Nalder2, Yael Groverover6, Monique Gignac7, Dennisse Bonilla1, Wils Nielsen8, Nicole Anderson9, Carmela Tartaglia10, Behdin Nowrouzi-Kia2 and Zahi Touma2, 1University Health Network, Toronto, ON, Canada, 2University of Toronto, Toronto, ON, Canada, 3University Health Network, University of Toronto, Toronto, ON, Canada, 4University of Manitoba, Institute for Work & Health, Winnipeg, MB, Canada, 5Michelle Vitti Psychotherapy and Counselling, Toronto, ON, Canada, 6NYU Steinhardt, New York, NY, 7Institute for Work & Health, Toronto, ON, Canada, 8University of Toronto, Markham, ON, Canada, 9Schroeder Arthritis Institute, Krembil Research Institute, University Health Network and University of Toronto, Toronto, ON, Canada, 10Krembil Brain Institute, University Health Network, University of Toronto, Toronto, ON, Canada

Meeting: ACR Convergence 2023

Keywords: Cognitive dysfunction, Qualitative Research, quality of life, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 14, 2023

Title: (2257–2325) SLE – Diagnosis, Manifestations, & Outcomes Poster III

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Cognitive impairment (CI) in systemic lupus erythematosus (SLE) negatively impacts health-related quality of life leading to activity limitations. This qualitative study aimed to (1) explore the effect of SLE-related CI on activities of daily living and life role participation; and (2) describe factors influencing activity restriction and life role participation.

Methods: Semi-structured, in-depth interviews probing living with CI in SLE were conducted with 24 adults living with SLE. Sociodemographic and clinical data, objective cognitive function (ACR-NB), and subjective cognitive function (PDQ-20) were collected. Participants were categorized into four groups of CI to perform a qualitative thematic analysis guided by a framework analytical approach. The groupings were defined as objective and subjective CI (Group 1), objective CI (Group 2), subjective CI (Group 3), and no CI (Group 4). Themes emerged using both inductive and deductive methods of data analysis.

Results: All participants met ACR classification criteria for SLE with a mean age of 42 ±13 years, SLE disease duration 13 ±10 years, SLEDAI (disease activity index) of 2.2 ±2.5, SDI (disease damage index) of 1.0±1.3, and prednisone daily dose of 3.4 mg/d ±6.0. Group sample sizes consisted of 11 participants in group 1, five in group 2, six in group 3, and 2 in group 4. Participants reported ongoing problems in multiple cognitive domains (memory, language, etc.) with multiple perceived causes. CI was felt to impact work, social, domestic and family life, health, and independence. Five overarching themes were represented in the data: (1) characterization of SLE-reported CI; (2) perceived cause of CI; (3) perceived impact of CI on activities of daily living and life role participation (4) adaptations for managing CI; (5) influence of CI adaptations on activities of daily living and life role participation. Figure 1 summarises the five identified themes and how they interact.

There were few between-group descriptive differences in the themes that emerged from the thematic and framework analyses. However, those within a subjective CI group (either group 1 or 3) characterized the involvement of mental health difficulties in perpetuating or exacerbating their self-reported experience of CI. Those within a subjective CI group also employed more frequent and diverse adaptations to manage their mental health difficulty, which had a secondary effect on their experience of CI.

Conclusion: This study provides a better understanding of the patient experience of CI in SLE, how it impacts their lives, and what coping strategies they employ. It highlights the long-term challenges those with CI in SLE undergo and provides evidence for the urgent need to implement multidisciplinary treatment options. The lack of descriptive differences between the study’s CI groupings suggests that regardless of the “type” of CI defined, subjective or objective, the impact and challenges experienced by the patients remain the same.

When managing CI, it may be beneficial to evaluate and understand available psychosocial support resources to help identify and reinforce relevant adaptations to improve health-related quality of life.

Supporting image 1


Disclosures: M. Barraclough: None; A. Howe: None; A. Soberanis: None; M. Kakvan: None; V. Chattu: None; A. Bani-Fatemi: None; L. Engel: None; M. Vitti: None; E. Nalder: None; Y. Groverover: None; M. Gignac: None; D. Bonilla: None; W. Nielsen: None; N. Anderson: None; C. Tartaglia: None; B. Nowrouzi-Kia: None; Z. Touma: AstraZeneca, 2, GSK, 2.

To cite this abstract in AMA style:

Barraclough M, Howe A, Soberanis A, Kakvan M, Chattu V, Bani-Fatemi A, Engel L, Vitti M, Nalder E, Groverover Y, Gignac M, Bonilla D, Nielsen W, Anderson N, Tartaglia C, Nowrouzi-Kia B, Touma Z. The Effects of Systematic Lupus Erythematosus Related Cognitive Impairments on Activities of Daily Living and Life Role Participation: A Qualitative Framework Study [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/the-effects-of-systematic-lupus-erythematosus-related-cognitive-impairments-on-activities-of-daily-living-and-life-role-participation-a-qualitative-framework-study/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-effects-of-systematic-lupus-erythematosus-related-cognitive-impairments-on-activities-of-daily-living-and-life-role-participation-a-qualitative-framework-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology